VC firm
BioAdvance
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- Conshohocken, PA, United States
- Check size
- $500K to $1.5MSource (opens in a new tab)
- Legal name
- Biotechnology Greenhouse of Southeastern Pennsylvania
Claim, correct or request removal
Record updated 17 September 2026
About
We invest in early-stage life-science companies with the potential to enhance human well-being and quality of life.
Investment approach
- Thesis
- We work closely and partner with entrepreneurs to build transformational companies in the Mid-Atlantic region focused on improving human health.Source (opens in a new tab)
- Leads rounds
- Sometimes
- Lead policy
- We would consider leading rounds between $500,000 and $5 million, bringing expertise and capital to accelerate product development, market validation, and growth initiatives.
- Eligibility
- We focus on investments in companies headquartered in the Mid-Atlantic U.S., specifically along the I-95 corridor between New York City and Washington, D.C. We also require the CEO to be based in this region, ensuring strong leadership presence within our geographic focus.
- Traction requirement
- For digital health investments, we look for companies with proven product-market-fit and established market traction as demonstrated by a growing revenue stream.
- Investing status notes
- We’re an evergreen fund that continues to grow and invest.
Locations
- Headquarters
- Conshohocken, PA, United States
Loading relationship preview